Literature DB >> 19108655

Multivalent scaffolds for affinity maturation of small molecule cell surface binders and their application to prostate tumor targeting.

Valerie Humblet1, Preeti Misra, Kumar R Bhushan, Khaled Nasr, Yao-Sen Ko, Takashi Tsukamoto, Nadine Pannier, John V Frangioni, Wolfgang Maison.   

Abstract

Adamantane scaffolds for affinity maturation of prostate cancer specific ligands of low molecular mass are described. These scaffolds are modular and can be used for conjugation of up to three ligands and an additional effector molecule by standard peptide coupling techniques. The potential of the scaffolds is demonstrated with the multimerization of GPI 1, a prostate cancer specific small molecule. A detailed study of multimerized GPI conjugates with near-infrared fluorophores and their binding properties to different prostate cancer cell lines shows the specific binding of these conjugates to cell types positive for prostate specific membrane antigen (PSMA). We demonstrate that these conjugates allow the sensitive imaging of prostate cancer cells with NIR methodology and suggest that our adamantane scaffolds might be generally useful for affinity maturation of small molecules targeting cell surface epitopes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19108655      PMCID: PMC2628416          DOI: 10.1021/jm801033c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  40 in total

1.  99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

Authors:  S Liu; D S Edwards
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  On the nature of the multivalency effect: a thermodynamic model.

Authors:  Pavel I Kitov; David R Bundle
Journal:  J Am Chem Soc       Date:  2003-12-31       Impact factor: 15.419

3.  High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen.

Authors:  Valerie Humblet; Rena Lapidus; Larry R Williams; Takashi Tsukamoto; Camilo Rojas; Pavel Majer; Bunda Hin; Shunsuke Ohnishi; Alec M De Grand; Atif Zaheer; Jürgen T Renze; Akira Nakayama; Barbara S Slusher; John V Frangioni
Journal:  Mol Imaging       Date:  2005 Oct-Dec       Impact factor: 4.488

Review 4.  Polymer therapeutics: concepts and applications.

Authors:  Rainer Haag; Felix Kratz
Journal:  Angew Chem Int Ed Engl       Date:  2006-02-13       Impact factor: 15.336

5.  Design, synthesis, and characterization of conifer-shaped dendritic architectures.

Authors:  George R Newkome; Kishore K Kotta; Charles N Moorefield
Journal:  Chemistry       Date:  2006-05-03       Impact factor: 5.236

6.  Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase.

Authors:  P F Jackson; D C Cole; B S Slusher; S L Stetz; L E Ross; B A Donzanti; D A Trainor
Journal:  J Med Chem       Date:  1996-01-19       Impact factor: 7.446

7.  Synthesis of well-defined tower-shaped 1,3,5-trisubstituted adamantanes incorporating a macrocyclic trilactam ring system.

Authors:  Quan Li; Changshu Jin; Pavel A Petukhov; Aleksey V Rukavishnikov; Tatiana O Zaikova; Avinash Phadke; Donald H LaMunyon; Melissa D Lee; John F W Keana
Journal:  J Org Chem       Date:  2004-02-20       Impact factor: 4.354

8.  Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).

Authors:  Sangeeta R Banerjee; Catherine A Foss; Mark Castanares; Ronnie C Mease; Youngjoo Byun; James J Fox; John Hilton; Shawn E Lupold; Alan P Kozikowski; Martin G Pomper
Journal:  J Med Chem       Date:  2008-07-19       Impact factor: 7.446

9.  Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.

Authors:  Jeroen R Mesters; Cyril Barinka; Weixing Li; Takashi Tsukamoto; Pavel Majer; Barbara S Slusher; Jan Konvalinka; Rolf Hilgenfeld
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

10.  Production of multimeric prostate-specific membrane antigen small-molecule radiotracers using a solid-phase 99mTc preloading strategy.

Authors:  Preeti Misra; Valerie Humblet; Nadine Pannier; Wolfgang Maison; John V Frangioni
Journal:  J Nucl Med       Date:  2007-07-13       Impact factor: 10.057

View more
  19 in total

Review 1.  Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation.

Authors:  Sylvain Gioux; Hak Soo Choi; John V Frangioni
Journal:  Mol Imaging       Date:  2010-10       Impact factor: 4.488

2.  A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules.

Authors:  Andrew X Zhang; Ryan P Murelli; Cyril Barinka; Julien Michel; Alexandra Cocleaza; William L Jorgensen; Jacek Lubkowski; David A Spiegel
Journal:  J Am Chem Soc       Date:  2010-09-15       Impact factor: 15.419

3.  Synergistic targeting of cell membrane, cytoplasm, and nucleus of cancer cells using rod-shaped nanoparticles.

Authors:  Sutapa Barua; Samir Mitragotri
Journal:  ACS Nano       Date:  2013-09-27       Impact factor: 15.881

Review 4.  Comparison of prostate-specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer.

Authors:  Sagnik Sengupta; Mena Asha Krishnan; Sudeshna Chattopadhyay; Venkatesh Chelvam
Journal:  Cancer Rep (Hoboken)       Date:  2019-04-02

5.  Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancer.

Authors:  Ryan P Murelli; Andrew X Zhang; Julien Michel; William L Jorgensen; David A Spiegel
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

6.  Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.

Authors:  Ying Chen; Mrudula Pullambhatla; Sangeeta R Banerjee; Youngjoo Byun; Marigo Stathis; Camilo Rojas; Barbara S Slusher; Ronnie C Mease; Martin G Pomper
Journal:  Bioconjug Chem       Date:  2012-12-04       Impact factor: 4.774

Review 7.  The smart targeting of nanoparticles.

Authors:  Adam D Friedman; Sarah E Claypool; Rihe Liu
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  A low molecular weight PSMA-based fluorescent imaging agent for cancer.

Authors:  Ying Chen; Surajit Dhara; Sangeeta Ray Banerjee; Youngjoo Byun; Mrudula Pullambhatla; Ronnie C Mease; Martin G Pomper
Journal:  Biochem Biophys Res Commun       Date:  2009-10-08       Impact factor: 3.575

Review 9.  Prostate-specific membrane antigen as a target for cancer imaging and therapy.

Authors:  A P Kiess; S R Banerjee; R C Mease; S P Rowe; A Rao; C A Foss; Y Chen; X Yang; S Y Cho; S Nimmagadda; M G Pomper
Journal:  Q J Nucl Med Mol Imaging       Date:  2015-07-24       Impact factor: 2.346

10.  A multivalent approach of imaging probe design to overcome an endogenous anion binding competition for noninvasive assessment of prostate specific membrane antigen.

Authors:  Guiyang Hao; Amit Kumar; Timothy Dobin; Orhan K Oz; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-06-28       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.